138 related articles for article (PubMed ID: 2034990)
1. Nucleation time, cholesterol saturation index, and biliary bile acid pattern. A comparison in responders and nonresponders to systemic litholysis with bile acids.
Janowitz P; Wechsler JG; Janowitz A; Kuhn K; Swobodnik W; Ditschuneit H
Scand J Gastroenterol; 1991 Apr; 26(4):367-73. PubMed ID: 2034990
[TBL] [Abstract][Full Text] [Related]
2. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
3. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
[TBL] [Abstract][Full Text] [Related]
4. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
6. Medical management of cholesterol gallstones.
Abate MA
Drug Intell Clin Pharm; 1986 Feb; 20(2):106-15. PubMed ID: 3512222
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
Petroni ML; Jazrawi RP; Pazzi P; Lanzini A; Zuin M; Pigozzi MG; Fracchia M; Galatola G; Alvisi V; Heaton KW; Podda M; Northfield TC
Aliment Pharmacol Ther; 2001 Jan; 15(1):123-8. PubMed ID: 11136285
[TBL] [Abstract][Full Text] [Related]
8. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
Bateson MC; Hill A; Bouchier IA
Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
[TBL] [Abstract][Full Text] [Related]
12. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
Jüngst D; Brenner G; Pratschke E; Paumgartner G
J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
[TBL] [Abstract][Full Text] [Related]
13. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
15. [Drug cholelitholysis and the nucleation time].
Janowitz P; Swobodnik W; Wechsler JG; Fischer S; Ditschuneit H
Dtsch Med Wochenschr; 1989 Jun; 114(25):983-5. PubMed ID: 2737092
[TBL] [Abstract][Full Text] [Related]
16. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
Bateson MC; Ross PE; Murison J; Bouchier IA
Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
[TBL] [Abstract][Full Text] [Related]
18. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
Nilsell K
Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
[No Abstract] [Full Text] [Related]
19. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
20. Oral dissolution therapy for cholelithiasis: mix and match.
Phillips RS; Barkin JS
Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
